Monosodium glutamate (MSG): A villain and promoter of liver inflammation and dysplasiaYuko Nakanishi, M. Eric Gershwin, Koichi Tsuneyama et al.|Journal of Autoimmunity|2008Cited by 151
Spontaneous onset of nonalcoholic steatohepatitis and hepatocellular carcinoma in a mouse model of metabolic syndromeTakeshi Nishida, Johji Imura, Koichi Tsuneyama et al.|Laboratory Investigation|2012Cited by 56
Autoimmune Features in Metabolic Liver Disease: A Single-Center Experience and Review of the LiteratureKoichi Tsuneyama, Carlo Selmi, Hayato Baba et al.|Clinical Reviews in Allergy & Immunology|2013Cited by 44
Deficiency in Galectin-3 Promotes Hepatic Injury in CDAA Diet-Induced Nonalcoholic Fatty Liver DiseaseKazuhiro Nomoto, Koichi Tsuneyama, Takeshi Nishida et al.|The Scientific World JOURNAL|2012Cited by 30
Neonatal monosodium glutamate treatment causes obesity, diabetes, and macrovesicular steatohepatitis with liver nodules in <scp>DIAR</scp> miceKoichi Tsuneyama, Johji Imura, Takeshi Nishida et al.|Journal of Gastroenterology and Hepatology|2014Cited by 25